Caribou Biosciences, Inc. (CRBU) Reports Q2 Loss, Tops Revenue Estimates

Caribou Biosciences, Inc. (CRBU) came out with a quarterly loss of $0.42 per share versus the Zacks Consensus Estimate of a loss of$ 0.45. This compares to loss of $0.48 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of 6.67%. A quarter ago, it was expected that this company would post a loss of$ 0.39 per share when it actually produced a loss of $0.46, delivering a surprise of -17.95%. Over the last four quarters, the company ...